<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Valvular heart disease in older adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Valvular heart disease in older adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Valvular heart disease in older adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Dania Mohty, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sorin Pislaru, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Catherine M Otto, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kenneth E Schmader, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 02, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The diagnosis and management of valvular heart disease in older adults has been affected by the dramatic increase in life expectancy that began in the last half of the 20th century. In the United States, for example, the number of persons aged 80 years or older is expected to increase from 6.9 million in 1990 to approximately 25 million by the year 2050 [<a href="#rid1">1</a>]. As a result, degenerative valve disease is likely to become an increasing problem. Furthermore, the prevalence of valvular disease is increasing with age, with more than one in eight people age 75 and older having moderate or severe valve disease [<a href="#rid2">2</a>].</p><p>Fortunately, there have been major advances in cardiac surgery, which affect the consideration of surgical treatment in older patients who in the past may not have been surgical candidates. Among patients who survive the surgery and perioperative period, the level of function and quality of life and, in some studies, survival are the same as in a general population of age-matched subjects [<a href="#rid3">3-5</a>]. As a result, the classic view that surgery should be considered only for older patients in excellent general condition is being challenged as higher success rates are obtained in patients with comorbidities. Additionally, development of percutaneous valvular interventions will further increase therapeutic choices for older adults. Indeed, the success of transcatheter aortic valve implantation (TAVI) has spurred active development efforts for mitral and tricuspid valve disease [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/z/d/html/83110.html" rel="external">"Choice of intervention for severe calcific aortic stenosis"</a>.)</p><p>Studies have used various age criteria to identify older adults. Although there are no comprehensive population-based data regarding the prevalence of valvular heart disease, several studies have provided important information about the prevalence of significant valvular heart disease, stratified by age  (<a class="graphic graphic_table graphicRef77504" href="/z/d/graphic/77504.html" rel="external">table 1</a>). Aortic stenosis (AS), organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation are the most common valvular disorders in older adults.</p><p class="headingAnchor" id="H2"><span class="h1">AORTIC STENOSIS</span><span class="headingEndMark"> — </span>Calcific or degenerative aortic valve disease is a common valvular lesion encountered among older patients [<a href="#rid8">8-10</a>]. In the Helsinki Aging Study, 501 randomly selected males and females aged 75 to 86 underwent imaging and Doppler echocardiography [<a href="#rid9">9,10</a>]. The prevalence of at least moderate AS, defined as an aortic valve area (<a class="drug drug_general" data-topicid="8625" href="/z/d/drug information/8625.html" rel="external">AVA</a>) ≤1.2 cm<sup>2</sup> and velocity ratio ≤0.35, was 5 percent; the prevalence of critical AS (AVA ≤0.8 cm<sup>2</sup>, and velocity ratio ≤0.25) increased with age from 1 to 2 percent in persons 75 to 76 years of age up to almost 6 percent in those 86 years of age [<a href="#rid10">10</a>]. Moderate or severe AS was more frequent in females (8.8 versus 3.6 percent in males), but data were not adjusted for body size [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/8115.html" rel="external">"Aortic valve area in aortic stenosis in adults"</a>.)</p><p>Similar prevalence has been reported from referral centers and nursing home populations, with an even higher prevalence in those over 90 years of age [<a href="#rid11">11,12</a>].</p><p>The two most common causes of AS severe enough to require surgery are calcification of congenital bicuspid aortic valves and degenerative calcification of tricuspid aortic valves [<a href="#rid13">13,14</a>]. The relative distribution is importantly influenced by age, as illustrated in a study of 932 adults with isolated nonrheumatic AS who underwent operative excision of the valve [<a href="#rid14">14</a>]. Among patients over age 70, approximately 60 percent had a tricuspid valve and 40 percent had a bicuspid valve. In contrast, among patients between the ages of 50 and 70, approximately two-thirds had a bicuspid valve, one-third a tricuspid valve, and rare patients had a unicuspid valve. </p><p>AS in older patients may be accompanied by aortic regurgitation. In comparison, isolated aortic regurgitation due to aortic valve disease is uncommon in older adults [<a href="#rid15">15</a>]. (See <a class="local">'Aortic regurgitation'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h2">Risk factors for degenerative calcific AS</span><span class="headingEndMark"> — </span>The risk factors associated with the development of calcific AS in older adults are similar to those for atherosclerosis. As an example, the Cardiovascular Health Study evaluated 5201 subjects ≥65 years of age; the incidence of aortic sclerosis and AS was 26 and 2 percent overall and 37 and 2.6 percent among those more than 75 years of age [<a href="#rid16">16</a>]. The major independent clinical risk factors for degenerative aortic valve disease were:</p><p class="bulletIndent1"><span class="glyph">●</span>Age – Each 10-year increase in age was associated with a twofold increased risk.</p><p class="bulletIndent1"><span class="glyph">●</span>Male sex – Twofold excess risk.</p><p class="bulletIndent1"><span class="glyph">●</span>Current cigarette smoking – 35 percent increase in risk.</p><p class="bulletIndent1"><span class="glyph">●</span>A history of hypertension – 20 percent increase in risk.</p><p></p><p>High serum concentrations of lipoprotein(a) and low density lipoprotein cholesterol were also significant risk factors.</p><p class="headingAnchor" id="H569193"><span class="h3">Aortic valve sclerosis</span><span class="headingEndMark"> — </span>Aortic valve thickening (sclerosis) without stenosis is common in older adults, being found in 26 to 29 percent of individuals ≥65 years of age [<a href="#rid16">16,17</a>]. The prevalence is higher in older subjects: 35 percent between 75 and 84 years of age, and 48 percent of those aged 85 years and above [<a href="#rid16">16</a>]. It is usually detected on echocardiography requested for other indications, although some patients have a midsystolic ejection murmur.</p><p>Aortic valve sclerosis is clinically important because it can progress to AS and it is a marker for increased cardiovascular risk. Issues related to aortic valve sclerosis are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8123.html" rel="external">"Aortic valve sclerosis and pathogenesis of calcific aortic stenosis"</a>.)</p><p class="headingAnchor" id="H13898611"><span class="h2">Diagnosis of AS in older adults</span><span class="headingEndMark"> — </span>AS is staged based upon valve anatomy, valve hemodynamics, and hemodynamic (left ventricular) effects [<a href="#rid18">18,19</a>]. This staging system included the syndrome of symptomatic severe low gradient AS. This entity is particularly prevalent in older adults, and presents a diagnostic challenge. (See  <a class="medical medical_review" href="/z/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8114.html" rel="external">"Clinical manifestations and diagnosis of low gradient severe aortic stenosis"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Outcome of surgery</span><span class="headingEndMark"> — </span>Isolated aortic valve replacement (AVR) is being performed more frequently in older patients at almost any age, and approximately 60 to 70 percent of all valve surgery performed in older adults are for AS. The indications for surgery are the same as those for younger patients: severe AS with symptoms (angina, dyspnea, or syncope), a left ventricular ejection fraction (LVEF) less than 50 percent, or concurrent coronary artery bypass graft surgery (CABG) [<a href="#rid18">18,19</a>]. (See  <a class="medical medical_review" href="/z/d/html/8154.html" rel="external">"Indications for valve replacement for high gradient aortic stenosis in adults"</a>.)</p><p>However, emerging data suggests that an LVEF of 50 to 60 percent in the context of moderate AS predicts further deterioration of LV systolic function, and should be considered abnormal in patients with more than moderate AS [<a href="#rid20">20</a>].</p><p>Older patients with AS tend to have a poorer preoperative status than younger patients. This leads to higher in-hospital mortality in older patients, which ranges from 5 to 18 percent in various studies [<a href="#rid3">3,6,21-26</a>]. Among older adults, age is an important determinant of outcome. In one series, for example, patients ≥80 years of age had higher perioperative mortality than those 65 to 75 years of age (14 versus 4 percent) [<a href="#rid3">3</a>]. At least part of this difference was due to a much higher frequency of New York Heart Association functional class III or IV in the older group (86 versus 36 percent)  (<a class="graphic graphic_table graphicRef52683" href="/z/d/graphic/52683.html" rel="external">table 2</a>). More trials show, in general, lower perioperative mortality (6.4 percent in Partner Cohort A patients) [<a href="#rid6">6</a>].</p><p>Another factor related to the poorer outcome is extensive age-related valvular calcification, which is associated with friable tissues. This makes valve surgery particularly difficult in older adults, with a high risk of complications.</p><p>Patients undergoing aortic valve replacement generally have increased mortality if concurrent CABG is also performed. Mortality is also increased when aortic valve replacement is combined with procedures other than CABG (eg, mitral valve replacement or valve repair or aneurysm repair) [<a href="#rid21">21</a>]. (see <a class="local">'Coronary artery disease'</a> below)</p><p>Older patients who survive the perioperative period often do well [<a href="#rid3">3,21,25-27</a>]. This was illustrated in a retrospective review that evaluated the outcome after aortic valve replacement in 1100 patients ≥80 years of age [<a href="#rid25">25</a>]. The 30-day cardiac and all-cause mortalities were 4 and 6.6 percent, respectively, while the actuarial survival at one, five, and eight years was 89, 69, and 46 percent, respectively. After the first 30 postoperative days, 70 percent of deaths were due to noncardiac causes (most often malignancy, stroke, or pneumonia).</p><p>Older patients have excellent functional recovery and a marked improvement in quality of life, similar to what is observed in younger patients; their level of function and quality of life are the same as a general population of age-matched subjects [<a href="#rid3">3,4</a>]</p><p class="headingAnchor" id="H5"><span class="h3">Choice of aortic valve prosthesis</span><span class="headingEndMark"> — </span>The choice of prosthesis (bioprosthesis versus mechanical valve) is an important issue in aortic valve disease. The major problems with mechanical valves are thromboembolism and bleeding from chronic anticoagulation [<a href="#rid28">28</a>], while the major problem with bioprosthetic valves is their limited durability due to valve degeneration, although bioprosthetic valve thrombosis is now increasingly recognized [<a href="#rid29">29,30</a>]. (See  <a class="medical medical_review" href="/z/d/html/8154.html" rel="external">"Indications for valve replacement for high gradient aortic stenosis in adults"</a>.)</p><p>Early mortality and actuarial survival in older adults are similar with the two types of valves [<a href="#rid25">25</a>]. However, the longevity of a bioprosthetic valve is inversely related to age [<a href="#rid31">31-33</a>]. In one report, the actuarial estimate of the rate of structural deterioration of bioprosthetic aortic valves at 15 years varied from 63 percent between the ages of 40 and 49 (and perhaps higher under age 40) to 10 percent over age 70 [<a href="#rid31">31</a>]. Similar findings were noted in a Veterans’ Affairs trial in which the rate of bioprosthetic valve failure at 15 years varied from 26 percent under age 65 to 9 percent in patients ≥65 years of age [<a href="#rid32">32</a>]. The lower rate of valve failure in older adults is due at least in part to decreased activity in older patients. </p><p>The net effect is that the life expectancy of an octogenarian is shorter than the expected functional life of a bioprosthesis. As a result, a bioprosthetic valve is usually the best choice in older patients [<a href="#rid21">21,25,31,33,34</a>]. In the review cited above of aortic valve replacement in 1100 patients ≥80 years of age, a bioprosthetic valve was implanted in 88 percent [<a href="#rid25">25</a>]. A similar frequency of bioprosthetic valve use (81 percent) was reported in a series of 2447 patients ≥65 years of age who underwent aortic valve replacement between 1992 and 2004 at the Brigham and Women's Hospital in Boston [<a href="#rid34">34</a>].</p><p>Over the last years, there was a strong increase in the use of bioprosthetic valves. Indeed, bioprostheses made up 53.3 percent of an estimated 767,375 prosthetic valves implanted in the United States between 1998 and 2011, increasing from 37.7 percent between 1998 and 2001 to 63.6 percent between 2007 and 2011 [<a href="#rid35">35</a>]. For the entire period, bioprostheses were used in 65 percent of patients over the age of 75.  </p><p class="headingAnchor" id="H6"><span class="h3">Small aortic annulus and prosthesis-patient mismatch</span><span class="headingEndMark"> — </span>Older patients, particularly older females, tend to have a small aortic annulus; this has led to use of a small aortic prosthesis, which may leave a marked residual transprosthetic gradient, ie, a patient-prosthesis mismatch [<a href="#rid36">36-38</a>]. This mismatch may be associated with worse hemodynamics, less functional improvement, and higher in-hospital mortality, particularly in males [<a href="#rid37">37,39,40</a>]. Long-term outcome in patients with patient prosthesis mismatch remain controversial; however, most of the studies have found that early and late mortality and sudden death risk are greater when mismatch is present [<a href="#rid39">39,41-43</a>]. </p><p>The impact of mismatch may vary among patients. A study found the mismatch has a negative impact in young patients &lt;70 years, but not in older patients; and in patients with decreased LVEF (&lt;50 percent), but not in those with preserved LVEF [<a href="#rid44">44</a>]. Patients with body mass index (BMI) &gt;30 kg/m² with mismatch had similar survival compared with those with a BMI &lt;30 kg/m², suggesting that using body surface area (BSA) to index aortic valve area is not the best way to define mismatch in patients with obesity undergoing AVR. Further studies using an alternative definition of mismatch are needed to evaluate long-term outcome in patients with obesity with AVR. </p><p>Some surgeons suggest that a mechanical valve may be preferred in patients with a small aortic annulus. Mechanical valves have smaller transvalvular gradients than bioprostheses and provide better hemodynamics, especially in patients with a small annulus (&lt;21 mm) [<a href="#rid21">21</a>].</p><p>The options with a bioprosthetic valve include accepting the higher residual gradient of a bioprosthesis, enlarging the aortic annulus, the use of a stentless bioprosthetic valve, or use of a transcatheter valve. Aortic root enlargement permits the use of a bioprosthesis one or two sizes larger. Although this may prevent a patient-prosthesis mismatch, it adds to the complexity of the procedure [<a href="#rid45">45</a>]. Newer stentless bioprosthetic valves offer a larger orifice area with only a small transvalvular gradient so that enlargement of the annulus is infrequently required [<a href="#rid46">46,47</a>]. However, the durability of these stentless valves remains uncertain since long-term follow-up is not available. The incidence of severe patient-prosthesis mismatch is significantly lower with both balloon-expandable [<a href="#rid48">48</a>] and self-expanding transcatheter valves [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Percutaneous balloon valvotomy</span><span class="headingEndMark"> — </span>Percutaneous balloon valvotomy was initially introduced as an alternative to aortic valve replacement in older patients with AS. Early reports suggested older adults have limited benefit since the aortic valve is usually severely calcified without discernible commissural fusion, making it unsuitable for dilatation, and there has been a high incidence of residual or recurrent stenosis and serious complications, including death, stroke, aortic rupture, and aortic regurgitation [<a href="#rid50">50-52</a>]. (See  <a class="medical medical_review" href="/z/d/html/8141.html" rel="external">"Percutaneous balloon aortic valvotomy for native aortic stenosis in adults"</a>.) </p><p>As a result, balloon aortic valvotomy has traditionally been restricted to very high risk or inoperable patients. However, it can result in immediate improvement in hemodynamics and is palliative in patients with severe AS who are inoperable [<a href="#rid53">53</a>]. Patients who develop restenosis after aortic balloon valvotomy have undergone aortic valve replacement, with good long-term outcome [<a href="#rid51">51,54</a>]. Introduction of transcatheter aortic valve implantation (TAVI) has resulted in an increase in the number of aortic balloon valvuloplasty procedures, mainly due to increased referral of high-risk patients and to the emerging indication of bridge to TAVI [<a href="#rid55">55</a>] (see <a class="local">'Transcatheter aortic valve implantation'</a> below). Emergency TAVR has been reported in isolated cases, but given the need for complex imaging in terms of route and sizing for TAVI, it has not yet replaced valvotomy.</p><p class="headingAnchor" id="H569030"><span class="h2">Transcatheter aortic valve implantation</span><span class="headingEndMark"> — </span>TAVI is an excellent option for older patients with severe symptomatic AS. TAVI is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/83110.html" rel="external">"Choice of intervention for severe calcific aortic stenosis"</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">AORTIC REGURGITATION</span><span class="headingEndMark"> — </span>Aortic regurgitation is less common in older adults than AS and mitral regurgitation [<a href="#rid10">10,21,56,57</a>]. The reported prevalences may, due to the method of quantitation, overestimate the severity of regurgitation.</p><p class="bulletIndent1"><span class="glyph">●</span>In the Helsinki Aging Study, aortic regurgitation, mostly mild, was present in 29 percent of patients [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the Framingham Study, aortic regurgitation that was at least mild was present in 13 percent of subjects [<a href="#rid57">57</a>]. Age was a determinant of risk, as the odds ratio was 2.3 for each 10-year increase of age.</p><p></p><p>The most common causes for chronic aortic regurgitation in older adults are dilation of the ascending aorta resulting from hypertension or primary aortic disease, calcific aortic sclerosis, and, rarely, a bicuspid aortic valve. Acute aortic regurgitation is most often due to an aortic dissection or endocarditis. (See  <a class="medical medical_review" href="/z/d/html/8159.html" rel="external">"Clinical manifestations and diagnosis of chronic aortic regurgitation in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8166.html" rel="external">"Acute aortic regurgitation in adults"</a>.) </p><p>A special category is represented by periprosthetic aortic regurgitation after transcatheter aortic valve implantation (TAVI), presumably due to poor tolerance of volume overload in the face of significant left ventricular diastolic dysfunction in this patient population. Indeed, even mild degrees of periprosthetic aortic regurgitation after TAVI are associated with increased mortality, and outcomes with moderate or more periprosthetic aortic regurgitation are poor [<a href="#rid58">58,59</a>] (see  <a class="medical medical_review" href="/z/d/html/110074.html" rel="external">"Transcatheter aortic valve implantation: Complications", section on 'Post-TAVI aortic regurgitation'</a>). </p><p>While given less attention due to its lower incidence, periprosthetic valve regurgitation after surgically implanted aortic prostheses is equally detrimental. Indeed, in a propensity matched cohort of 86 patients with surgical valve replacement versus 86 with TAVI, peri-valvular regurgitation was associated with similar mortality. Excess mortality attributable to periprosthetic regurgitation was present in patients with low or intermediate Society of Thoracic Surgery (STS) risk scores, but not in those with high risk [<a href="#rid60">60</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>Aortic valve surgery for pure aortic regurgitation represents approximately 3 to 5 percent of valve surgeries in older adults [<a href="#rid26">26</a>]. Prophylactic surgery is often recommended in asymptomatic adults with chronic severe aortic regurgitation and evidence of left ventricular dysfunction or marked dilation. However, symptoms are the preferred indication in older patients, especially those over age 80. Mild symptoms and not advanced heart failure (HF) should alert the physician to consider surgery if the regurgitation is severe. (See  <a class="medical medical_review" href="/z/d/html/8160.html" rel="external">"Natural history and management of chronic aortic regurgitation in adults"</a>.)</p><p>There are limited data about the outcome of aortic valve surgery for isolated aortic regurgitation in older adults. Although aortic valve replacement is usually the treatment of choice for acute or chronic severe aortic regurgitation, aortic valve repair is sometimes possible in aortic regurgitation due to endocarditis, and valve-sparing operations are a major consideration in patients with aortic dissection. However, if conservative surgery in these patients is not possible or questionable, standard valve replacement should be performed. Increasing age is a risk factor for operative and long-term mortality. (See  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/8188.html" rel="external">"Management of acute type B aortic dissection"</a> and  <a class="medical medical_review" href="/z/d/html/8160.html" rel="external">"Natural history and management of chronic aortic regurgitation in adults", section on 'Aortic valve surgery'</a>.) </p><p class="headingAnchor" id="H11"><span class="h1">MITRAL REGURGITATION</span><span class="headingEndMark"> — </span>Mitral regurgitation is a common valvular abnormality in older adults. In a report from the Framingham Study of 3589 subjects who underwent color Doppler echocardiography, older age was associated with an increased prevalence of valvular regurgitation (odds ratio 1.3 per 10 year increase in age) [<a href="#rid57">57</a>]. Among males and females at least 60 years of age, mitral regurgitation that was at least mild was seen in 19 percent, while significant mitral regurgitation (at least moderate) was found in 4 and 1.9 percent.</p><p>Earlier non-population-based studies found a higher prevalence of significant mitral regurgitation, which was especially frequent in patients at least 60 years of age who had mitral annulus calcification (MAC) [<a href="#rid61">61,62</a>]. The higher prevalence may be explained by the combination of referral bias (ie, only patients with MAC), and lack of information about methods of quantification of severity of mitral regurgitation. In one series of 51 patients with an echocardiographic diagnosis of MAC, for example, mild or moderate to severe mitral regurgitation was seen in 22 and 33 percent, respectively [<a href="#rid62">62</a>]. (See  <a class="medical medical_review" href="/z/d/html/8122.html" rel="external">"Clinical manifestations and diagnosis of mitral annular calcification"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>There are three major causes of significant mitral regurgitation [<a href="#rid63">63</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Organic or primary mitral regurgitation due to intrinsic disease of the mitral leaflets or subvalvular apparatus (eg, mitral valve prolapse, flail mitral leaflet, ruptured chordae tendineae, or calcific degeneration).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functional or secondary ischemic mitral regurgitation due to reversible ischemia or papillary muscle infarction, with or without rupture, associated with an acute myocardial infarction. (See  <a class="medical medical_review" href="/z/d/html/102361.html" rel="external">"Chronic secondary mitral regurgitation: General management and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functional or secondary non ischemic mitral regurgitation resulting from papillary muscle apical displacement associated with annular dilatation induced by left ventricular enlargement of any cause. </p><p></p><p>In older patients, the most common causes of mitral regurgitation that is of sufficient severity to lead to referral for mitral valve surgery are prolapse (ie, myxomatous degeneration) and ischemic heart disease [<a href="#rid64">64-66</a>]. One report, for example, evaluated 614 patients undergoing mitral valve surgery [<a href="#rid66">66</a>]. The 190 patients who were ≥70 years of age were more likely to have degenerative mitral regurgitation (60 versus 39 percent in younger patients) and coronary heart disease (28 percent versus 12 percent).</p><p class="headingAnchor" id="H13"><span class="h2">Outcome of surgery</span><span class="headingEndMark"> — </span>Chronic mitral regurgitation is the second most common reason for valve surgery in older adults, representing 30 to 35 percent of cases [<a href="#rid24">24,26</a>]. Although surgery may be recommended for young asymptomatic patients with early evidence of left ventricular dysfunction , it is often preferable in patients over age 80 to proceed with surgery only when symptoms are present. (See  <a class="medical medical_review" href="/z/d/html/8149.html" rel="external">"Chronic primary mitral regurgitation: Indications for intervention"</a> and  <a class="medical medical_review" href="/z/d/html/102361.html" rel="external">"Chronic secondary mitral regurgitation: General management and prognosis"</a>.)</p><p>Operative mortality is generally higher in patients with functional regurgitation due to ischemic cardiomyopathy (see <a class="local">'Effect of ischemic mitral regurgitation on mortality'</a> below).Extensive valvular calcification makes both valve repair and replacement more difficult [<a href="#rid67">67</a>]. </p><p>The outcome after surgery in older patients varies with age and disease severity and is better after mitral valve repair than replacement [<a href="#rid64">64,66,68-71</a>]. In the above series of 614 patients (190 of whom were ≥70 years of age), the operative mortality after mitral valve repair or replacement was similar in the two age groups (3.7 and 3.5 percent), but seven-year survival was lower in the older patients (49 versus 77 percent) [<a href="#rid66">66</a>]. However, freedom from complications-related death at seven years was similar in the two groups (90 and 93 percent) in who underwent surgery while in New York Heart Association (NYHA) class I or II  (<a class="graphic graphic_table graphicRef52683" href="/z/d/graphic/52683.html" rel="external">table 2</a>) with a left ventricular ejection fraction ≥40 percent. This observation suggests that late surgery contributes more than age to the worse outcome in mitral valve surgery in older adults. (see <a class="local">'Mitral valve repair'</a> below)</p><p>The outcomes may not be so favorable in patients ≥80 years of age [<a href="#rid21">21,69,70</a>]. In a report of 86 such patients who underwent isolated mitral valve replacement with a bioprosthetic or mechanical valve, the 30-day mortality was 10.4 percent [<a href="#rid69">69</a>]. Actuarial survival at one, three, and five years was 79, 64, and 41 percent; the values were the same with both types of valves. Two-thirds of the late deaths were due to noncardiac causes. Octogenarians who have combined coronary artery bypass graft surgery (CABG) and mitral valve replacement have an even higher in-hospital mortality (19.6 versus 12.2 percent in younger patients in a report from the National Cardiovascular Network) [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H14"><span class="h3">Mitral valve repair</span><span class="headingEndMark"> — </span>Mitral valve repair, if possible, is the surgical treatment of choice for mitral regurgitation. It preserves all of the functional components of the native valve, avoids the use of a prosthesis with its attendant complications, and overall is associated with lower rates of morbidity and mortality than mitral valve replacement. There are conflicting data as to whether the survival benefit compared to valve replacement is or is not seen in patients over age 60 [<a href="#rid72">72,73</a>]. (See  <a class="medical medical_review" href="/z/d/html/140775.html" rel="external">"Chronic primary mitral regurgitation: Choice of intervention", section on 'Surgical valve repair versus replacement'</a>.)</p><p>Mitral valve repair produces good results in older patients. This was illustrated in a study that evaluated 278 patients ≥70 years of age who underwent mitral valve reconstruction, primarily with an annuloplasty ring [<a href="#rid74">74</a>]. The in-hospital mortality was 6.5 percent with valve repair alone, 13.2 percent when annuloplasty was combined with another reparative procedure, and 17 percent when combined with CABG.</p><p>An excellent outcome in patients over age 75 was noted in a study of 1344 patients undergoing mitral valve repair at Mayo Clinic between 1980 and 1995 [<a href="#rid71">71,75</a>]. During this interval, perioperative mortality in older adults (total 284 patients &gt;75 years of age) decreased dramatically from 27 percent between 1980 and 1983 to 5 percent between 1992 and 1995. The rate of mitral repair in older patients was similar to younger patients, with an overall increase from 30 to 84 percent during the same interval. Furthermore, five-year survival of older patients after mitral valve surgery was similar to their life expectancy (93 percent of expected), an outcome that was similar to that of younger patients. </p><p>Various percutaneous mitral valve repair techniques are currently being evaluated. So far, the largest experience is with the MitraClip [<a href="#rid76">76</a>]; this device approximates the mitral leaflet edges and is commercially available in Europe, Israel, and Australia, but investigational in the United States. While the MitraClip was inferior to surgical correction in terms of overall reduction of mitral regurgitation and need for re-intervention, this is a procedure that could be helpful in inoperable patients, and is approved for clinical use in patients with primary (organic) mitral valve disease. The MitraClip has also been used in patients with secondary (functional) mitral regurgitation, but this indication is not approved yet in the United States. Two recent trials in patients with functional mitral regurgitation (Mitra-FR and COAPT) have reported very different results. There was no advantage of percutaneous intervention over medical therapy in Mitra-FR [<a href="#rid77">77</a>], while there was a significant improvement in both rehospitalization for HF and mortality in COAPT [<a href="#rid78">78</a>]. (See  <a class="medical medical_review" href="/z/d/html/140775.html" rel="external">"Chronic primary mitral regurgitation: Choice of intervention", section on 'Transcatheter edge-to-edge repair'</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">MITRAL STENOSIS</span><span class="headingEndMark"> — </span>Mitral stenosis remains a valvular disease of predominantly young people, and rheumatic fever remains the leading cause of mitral stenosis in all age groups [<a href="#rid63">63</a>]. (See  <a class="medical medical_review" href="/z/d/html/8137.html" rel="external">"Pathophysiology and natural history of mitral stenosis"</a>.) </p><p>Although valvular mitral stenosis is rarely seen in older patients, mitral obstruction may be produced by protuberant mitral annular calcification (MAC). In one series of 100 patients ≥62 years of age with MAC, 6 percent had mitral obstruction [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/z/d/html/8122.html" rel="external">"Clinical manifestations and diagnosis of mitral annular calcification"</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>The preferred surgical treatment for severe mitral stenosis is repair (commissurotomy). Mitral valve replacement is unfortunately often necessary since the valvular morphology in older adults is usually unfavorable (extensive calcification, rigidity, and retraction of all of the valve components), making the valve unamenable to commissurotomy. (See  <a class="medical medical_review" href="/z/d/html/8140.html" rel="external">"Surgical and investigational approaches to management of mitral stenosis"</a>.)</p><p>Percutaneous balloon valvuloplasty is the procedure of choice with a favorable valvular morphology. It has a low risk and performed as well as surgical commissurotomy in randomized trials involving mostly younger patients. However, it is not indicated in patients with mitral obstruction due to mitral annular calcification, and there is a possibility of restenosis and need for valve repair during follow-up. (See  <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">"Percutaneous mitral balloon commissurotomy in adults"</a>.)</p><p>The outcome after percutaneous balloon valvuloplasty can be illustrated by the following findings:</p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 75 patients ≥70 years of age, the procedural mortality was 4 percent, and the initial results in the survivors were good, with an increase in valve area to ≥1.5 cm<sup>2</sup> in the absence of significant mitral regurgitation being achieved in 66 percent [<a href="#rid79">79</a>]. However, at four years, the actuarial rate of survival free of operation was 59 percent and New York Heart Association (NYHA) class I or II persisted in only 34 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a second study of 80 patients more than 70 years of age, valve area increased in all patients from 0.84 to 1.59 cm<sup>2</sup> [<a href="#rid80">80</a>]. The one- and five-year rates of survival without the need for valve replacement were 51 and 25 percent among the 55 patients who were unsuitable for valve surgery (frailty or associated disease), and 64 and 36 percent in the 25 patients who were considered suitable candidates for valve surgery.</p><p></p><p>As discussed separately, symptomatic severe calcific mitral stenosis cannot be treated by percutaneous mitral valve balloon valvotomy and mitral valve surgery for this condition is technically difficult and associated with high operative morbidity and mortality. Limited data are available on transcatheter mitral valve implantation for severe calcific mitral stenosis. (See  <a class="medical medical_review" href="/z/d/html/116169.html" rel="external">"Management and prognosis of mitral annular calcification", section on 'Mitral valve intervention'</a>.)</p><p class="headingAnchor" id="H13899058"><span class="h1">TRICUSPID REGURGITATION</span><span class="headingEndMark"> — </span>Tricuspid regurgitation is a very common valvular issue. Indeed, regurgitation was noted in up to 84 percent of patients in a review of 5223 consecutive echocardiographic studies; moderate or more regurgitation was associated with increased mortality [<a href="#rid81">81</a>]. In the Framingham Heart Study, 74 percent of males and 86 percent of females over 70 years old had tricuspid regurgitation (2 and 6 percent with more than moderate tricuspid regurgitation in males and females, respectively) [<a href="#rid57">57</a>]. While tricuspid regurgitation is very prevalent in older adults, very little is known about its specifics in this population, although age is consistently reported as a risk factor for overall poor outcome and increased surgical risk [<a href="#rid81">81,82</a>]. (See  <a class="medical medical_review" href="/z/d/html/8119.html" rel="external">"Etiology, clinical features, and evaluation of tricuspid regurgitation"</a>.)</p><p class="headingAnchor" id="H13899142"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>Major causes of tricuspid regurgitation are:</p><p class="bulletIndent1"><span class="glyph">●</span>Primary or organic tricuspid regurgitation due to intrinsic disease of the tricuspid leaflets or subvalvular apparatus (eg, tricuspid valve prolapse, flail leaflet/ruptured chordae tendineae, impingement by device lead).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Secondary or functional tricuspid regurgitation:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Due to left-sided heart disease and/or pulmonary hypertension. Regurgitation is caused by valvular tethering/tenting due to RV enlargement [<a href="#rid83">83</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Isolated functional tricuspid regurgitation (without evidence of pulmonary hypertension or organic tricuspid disease) due to annular/right ventricular basal enlargement [<a href="#rid83">83</a>]. This type of tricuspid valve disease is associated with aging and presence of atrial fibrillation.</p><p></p><p class="headingAnchor" id="H13899200"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>Medical management consists of diuretics as well as management of associated left-sided/pulmonary pathology. </p><p>Tricuspid valve surgery is recommended in patients with severe tricuspid regurgitation undergoing left-sided valve surgery [<a href="#rid18">18,19</a>].</p><p>The evidence for other indications for tricuspid valve surgery is less well established, as reflected by some differences in recommendations among major society guidelines [<a href="#rid18">18,19</a>]. The indications are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">"Management and prognosis of tricuspid regurgitation", section on 'Indications'</a>.)</p><p>Tricuspid valve repair is preferred over replacement; when the latter is considered, large-diameter bioprosthesis is preferred over mechanical valves [<a href="#rid19">19</a>]. Reoperation on the tricuspid valve in cases of persistent tricuspid regurgitation after mitral valve surgery carries a high risk, mostly due to the clinical condition of the patient (see  <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">"Management and prognosis of tricuspid regurgitation"</a>). Numerous percutaneous approaches to tricuspid valve repair are being evaluated.</p><p class="headingAnchor" id="H17"><span class="h1">UNDERLYING ATHEROSCLEROSIS</span><span class="headingEndMark"> — </span>The presence of underlying coronary or aortic atherosclerosis affects the treatment and outcome of older patients in whom surgery is considered for valvular disease [<a href="#rid18">18,19</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Coronary artery disease</span><span class="headingEndMark"> — </span>Coronary artery disease (CAD) is common in older patients and is often present in those with valvular heart disease. In large series of older patients undergoing surgery for valvular disease, 30 to 50 percent also underwent coronary artery bypass graft surgery (CABG) [<a href="#rid5">5,26,84</a>]. Coronary disease can be a concurrent problem or, in patients with ischemic mitral regurgitation, the cause of the valvular disorder [<a href="#rid65">65</a>]. In both of these settings, CHD is associated with excess short- and long-term mortality; however, the magnitude of effect is different.</p><p class="headingAnchor" id="H19"><span class="h3">Effect of CAD on mortality</span><span class="headingEndMark"> — </span>Among older patients with concurrent CHD of sufficient severity to require CABG at the time of valve surgery for nonischemic valvular disease, most series have noted increased in-hospital mortality compared to those undergoing valve surgery alone [<a href="#rid21">21,24,84</a>].</p><p>In one study of 752 patients, for example, 242 patients (32 percent) had significant coronary disease; 208 of these patients underwent CABG at the time of valve surgery [<a href="#rid84">84</a>]. The presence of CHD was an independent predictor of in-hospital mortality (odds ratio 2.35) and late mortality (hazard ratio 1.57). A similar increase in risk was found in a series of 191 octogenarians [<a href="#rid24">24</a>]. Among those undergoing elective surgery, the perioperative mortality was higher in those undergoing aortic valve replacement plus CABG (17.9 versus 9.6 percent in those undergoing aortic valve replacement alone).</p><p>Several other findings have been noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Mortality with combined surgery is higher in patients with left ventricular failure and those requiring urgent surgery [<a href="#rid24">24</a>] as well as in octogenarians compared to younger patients [<a href="#rid70">70</a>]. Not surprisingly, patients without other significant comorbidities do better [<a href="#rid26">26,70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aortic valve surgery plus CABG is associated with a higher in-hospital mortality than CABG alone: 17.9 versus 5.6 percent [<a href="#rid24">24</a>] and 10.1 versus 8.1 percent in octogenarians as well as 7.9 versus 3.0 percent in younger patients [<a href="#rid70">70</a>]. Postoperative morbidity, such as renal failure and stroke, is also increased [<a href="#rid70">70</a>].</p><p></p><p>In contrast to these observations, other series have found no significant difference in in-hospital mortality among patients undergoing CABG, aortic valve replacement, or both procedures [<a href="#rid26">26,85</a>].</p><p>Among older patients who undergo CABG and mitral valve surgery, most [<a href="#rid24">24,70,74,85</a>], but not all studies [<a href="#rid26">26</a>], have found increased in-hospital mortality compared to CABG and aortic valve replacement. In one review of over 4700 octogenarians, the respective values were 19.6 versus 10.1 percent overall and 18.2 versus 7 percent in those with no other significant comorbidities [<a href="#rid70">70</a>]. The worse outcome with mitral valve surgery is thought to reflect the frequently ischemic nature of mitral regurgitation, with damage occurring to both valve and myocardium [<a href="#rid85">85</a>]. As with aortic valve surgery, in-hospital mortality is higher with combined mitral valve surgery and CABG compared to mitral valve surgery alone (17 versus 6.5 percent in one series) [<a href="#rid74">74</a>].</p><p class="headingAnchor" id="H20"><span class="h3">Effect of ischemic mitral regurgitation on mortality</span><span class="headingEndMark"> — </span>Among patients with ischemic mitral regurgitation, the operative mortality is generally higher than for other types of mitral regurgitation and the outcome and procedure vary with the severity of regurgitation. (See  <a class="medical medical_review" href="/z/d/html/102361.html" rel="external">"Chronic secondary mitral regurgitation: General management and prognosis"</a>.)</p><p class="headingAnchor" id="H21"><span class="h2">Aortic atherosclerosis</span><span class="headingEndMark"> — </span>The aorta is an important source of emboli in patients with unexplained stroke and arterial emboli. Older patients considered for valvular surgery are more likely to have aortic atherosclerosis. In such patients, any manipulation of the aorta during surgery, including aortic cannulation for arterial inflow during cardiopulmonary bypass or aortic cross-clamping, may fragment a plaque, resulting in embolization. (See  <a class="medical medical_review" href="/z/d/html/8197.html" rel="external">"Thromboembolism from aortic plaque"</a>.)</p><p class="headingAnchor" id="H435028342"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a>.)</p><p class="headingAnchor" id="H569015"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Aortic stenosis (AS) and mitral regurgitation are the most common valvular disorders in older adults. (See <a class="local">'Introduction'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risk factors associated with calcific AS in older adults are similar to those for atherosclerosis. (See <a class="local">'Risk factors for degenerative calcific AS'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diagnosis of AS may be more complex in older adults due to the prevalence of “low-gradient severe AS”. In such cases, quantification of aortic valve calcification by computed tomography may prove useful. (See <a class="local">'Diagnosis of AS in older adults'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Older patients with AS tend to have poorer preoperative status and higher operative mortality with aortic valve replacement. However, those who survive the perioperative period often do well and have marked improvement in quality of life. (See <a class="local">'Outcome of surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When aortic valve replacement is indicated, a bioprosthetic valve is generally preferred to a mechanical valve in older patients in whom life expectancy is shorter than the expected function life of the bioprosthesis. (See <a class="local">'Choice of aortic valve prosthesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Transcatheter aortic valve replacement is the main choice for patients with severe symptomatic AS who are considered inoperable for surgical aortic valve replacement, and is associated with lower rates of patient prosthesis mismatch. (See  <a class="medical medical_review" href="/z/d/html/8141.html" rel="external">"Percutaneous balloon aortic valvotomy for native aortic stenosis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The most common causes for chronic aortic regurgitation in older adults are dilation of the ascending aorta resulting from hypertension or primary aortic disease, calcific aortic sclerosis, and, rarely, a bicuspid aortic valve. Acute aortic regurgitation is most often due to an aortic dissection or endocarditis. (See <a class="local">'Aortic regurgitation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In older adults, the most common causes of significant mitral regurgitation referred for mitral valve surgery are primary mitral valve disease and ischemic heart disease. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Surgery for severe chronic mitral regurgitation may be recommended for young asymptomatic patients with or without early evidence of left ventricular dysfunction , but in patients over age 80, although early surgery can be discussed, it is often preferred to proceed with surgery when symptoms are present. (See  <a class="medical medical_review" href="/z/d/html/8149.html" rel="external">"Chronic primary mitral regurgitation: Indications for intervention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mitral stenosis is relatively uncommon in older adults. The predominant cause is rheumatic fever. Calcific mitral stenosis due to protuberant annular calcification is occasionally seen. (See <a class="local">'Mitral stenosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with symptomatic mitral stenosis, percutaneous balloon valvuloplasty is the procedure of choice if valvular morphology is favorable. However, it is not indicated in patients with mitral obstruction due to mitral annular calcification. Transcatheter mitral valve implantation is being investigated for calcific mitral stenosis. (See <a class="local">'Treatment'</a> above.)  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coronary heart disease is common in older patients with valvular disease. When valve surgery is indicated in older patients, coronary angiography is indicated to assess the need for concomitant coronary artery bypass surgery. (See <a class="local">'Underlying atherosclerosis'</a> above.)</p><p></p><p class="headingAnchor" id="H859785588"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Maurice Enriquez-Sarano, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Spencer, G. US bureau of the census: Projections of the population of the united states, by age, sex and race: 1988 to 2080. Current Population 1989. p.1018.</li><li><a class="nounderline abstract_t">Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005.</a></li><li><a class="nounderline abstract_t">Olsson M, Granström L, Lindblom D, et al. Aortic valve replacement in octogenarians with aortic stenosis: a case-control study. J Am Coll Cardiol 1992; 20:1512.</a></li><li><a class="nounderline abstract_t">Olsson M, Janfjäll H, Orth-Gomér K, et al. Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients. Eur Heart J 1996; 17:583.</a></li><li><a class="nounderline abstract_t">Shapira OM, Kelleher RM, Zelingher J, et al. Prognosis and quality of life after valve surgery in patients older than 75 years. Chest 1997; 112:885.</a></li><li><a class="nounderline abstract_t">Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187.</a></li><li><a class="nounderline abstract_t">Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597.</a></li><li><a class="nounderline abstract_t">Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231.</a></li><li><a class="nounderline abstract_t">Iivanainen AM, Lindroos M, Tilvis R, et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996; 78:97.</a></li><li><a class="nounderline abstract_t">Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21:1220.</a></li><li><a class="nounderline abstract_t">Aronow WS, Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol 1991; 67:776.</a></li><li><a class="nounderline abstract_t">Tunick PA, Freedberg RS, Kronzon I. Cardiac findings in the very elderly: analysis of echocardiography in fifty-eight nonagenarians. Gerontology 1990; 36:206.</a></li><li><a class="nounderline abstract_t">Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc 1987; 62:119.</a></li><li><a class="nounderline abstract_t">Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920.</a></li><li><a class="nounderline abstract_t">Roberts WC, Ko JM, Moore TR, Jones WH 3rd. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006; 114:422.</a></li><li><a class="nounderline abstract_t">Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630.</a></li><li><a class="nounderline abstract_t">Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341:142.</a></li><li><a class="nounderline abstract_t">Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72.</a></li><li><a class="nounderline abstract_t">Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43:561.</a></li><li><a class="nounderline abstract_t">Ito S, Miranda WR, Nkomo VT, et al. Reduced Left Ventricular Ejection Fraction in Patients With Aortic Stenosis. J Am Coll Cardiol 2018; 71:1313.</a></li><li><a class="nounderline abstract_t">Elayda MA, Hall RJ, Reul RM, et al. Aortic valve replacement in patients 80 years and older. Operative risks and long-term results. Circulation 1993; 88:II11.</a></li><li><a class="nounderline abstract_t">Bessou JP, Bouchart F, Angha S, et al. Aortic valvular replacement in octogenarians. Short-term and mid-term results in 140 patients. Cardiovasc Surg 1999; 7:355.</a></li><li><a class="nounderline abstract_t">Gilbert T, Orr W, Banning AP. Surgery for aortic stenosis in severely symptomatic patients older than 80 years: experience in a single UK centre. Heart 1999; 82:138.</a></li><li><a class="nounderline abstract_t">Freeman WK, Schaff HV, O'Brien PC, et al. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol 1991; 18:29.</a></li><li><a class="nounderline abstract_t">Asimakopoulos G, Edwards MB, Taylor KM. Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry. Circulation 1997; 96:3403.</a></li><li><a class="nounderline abstract_t">Akins CW, Daggett WM, Vlahakes GJ, et al. Cardiac operations in patients 80 years old and older. Ann Thorac Surg 1997; 64:606.</a></li><li><a class="nounderline abstract_t">Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35:747.</a></li><li><a class="nounderline abstract_t">Kvidal P, Bergström R, Malm T, Ståhle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 2000; 21:1099.</a></li><li><a class="nounderline abstract_t">Egbe AC, Pislaru SV, Pellikka PA, et al. Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors. J Am Coll Cardiol 2015; 66:2285.</a></li><li><a class="nounderline abstract_t">Makkar RR, Fontana G, Jilaihawi H, et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med 2015; 373:2015.</a></li><li><a class="nounderline abstract_t">Yun KL, Miller DC, Moore KA, et al. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg 1995; 60:S221.</a></li><li><a class="nounderline abstract_t">Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36:1152.</a></li><li><a class="nounderline abstract_t">Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003; 41:893.</a></li><li><a class="nounderline abstract_t">Cohn LH. Use of heart valves in older patients. Circulation 2005; 111:2152.</a></li><li><a class="nounderline abstract_t">Isaacs AJ, Shuhaiber J, Salemi A, et al. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg 2015; 149:1262.</a></li><li><a class="nounderline abstract_t">Arom KV, Goldenberg IF, Emery RW. Long-term clinical outcome with small size Standard St Jude Medical valves implanted in the aortic position. J Heart Valve Dis 1994; 3:531.</a></li><li><a class="nounderline abstract_t">Pibarot P, Dumesnil JG, Lemieux M, et al. Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity and mortality after aortic valve replacement with a bioprosthetic heart valve. J Heart Valve Dis 1998; 7:211.</a></li><li><a class="nounderline abstract_t">Franzen SF, Huljebrant IE, Konstantinov IE, et al. Aortic valve replacement for aortic stenosis in patients with small aortic root. J Heart Valve Dis 1996; 5 Suppl 3:S284.</a></li><li><a class="nounderline abstract_t">Kratz JM, Sade RM, Crawford FA Jr, et al. The risk of small St. Jude aortic valve prostheses. Ann Thorac Surg 1994; 57:1114.</a></li><li><a class="nounderline abstract_t">Adams DH, Chen RH, Kadner A, et al. Impact of small prosthetic valve size on operative mortality in elderly patients after aortic valve replacement for aortic stenosis: does gender matter? J Thorac Cardiovasc Surg 1999; 118:815.</a></li><li><a class="nounderline abstract_t">Sawant D, Singh AK, Feng WC, et al. Nineteen-millimeter aortic St. Jude Medical heart valve prosthesis: up to sixteen years' follow-up. Ann Thorac Surg 1997; 63:964.</a></li><li><a class="nounderline abstract_t">Medalion B, Lytle BW, McCarthy PM, et al. Aortic valve replacement for octogenarians: are small valves bad? Ann Thorac Surg 1998; 66:699.</a></li><li><a class="nounderline abstract_t">Barner HB, Labovitz AJ, Fiore AC. Prosthetic valves for the small aortic root. J Card Surg 1994; 9:154.</a></li><li><a class="nounderline abstract_t">Mohty D, Dumesnil JG, Echahidi N, et al. Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. J Am Coll Cardiol 2009; 53:39.</a></li><li><a class="nounderline abstract_t">Sommers KE, David TE. Aortic valve replacement with patch enlargement of the aortic annulus. Ann Thorac Surg 1997; 63:1608.</a></li><li><a class="nounderline abstract_t">David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: a case-match study. J Thorac Cardiovasc Surg 1998; 116:236.</a></li><li><a class="nounderline abstract_t">David TE. Aortic valve replacement with stentless porcine bioprostheses. J Card Surg 1998; 13:344.</a></li><li><a class="nounderline abstract_t">Pibarot P, Weissman NJ, Stewart WJ, et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. J Am Coll Cardiol 2014; 64:1323.</a></li><li><a class="nounderline abstract_t">Zorn GL 3rd, Little SH, Tadros P, et al. Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg 2016; 151:1014.</a></li><li><a class="nounderline abstract_t">Bernard Y, Etievent J, Mourand JL, et al. Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old. J Am Coll Cardiol 1992; 20:796.</a></li><li><a class="nounderline abstract_t">Soyer R, Bouchart F, Bessou JP, et al. Aortic valve replacement after aortic valvuloplasty for calcified aortic stenosis. Eur J Cardiothorac Surg 1996; 10:977.</a></li><li><a class="nounderline abstract_t">Hara H, Pedersen WR, Ladich E, et al. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance? Circulation 2007; 115:e334.</a></li><li><a class="nounderline abstract_t">Eltchaninoff H, Cribier A, Tron C, et al. Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. Eur Heart J 1995; 16:1079.</a></li><li><a class="nounderline abstract_t">Lieberman EB, Wilson JS, Harrison JK, et al. Aortic valve replacement in adults after balloon aortic valvuloplasty. Circulation 1994; 90:II205.</a></li><li><a class="nounderline abstract_t">Saia F, Marrozzini C, Ciuca C, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention 2013; 8:1388.</a></li><li><a class="nounderline abstract_t">Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.</a></li><li><a class="nounderline abstract_t">Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83:897.</a></li><li><a class="nounderline abstract_t">Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366:1686.</a></li><li><a class="nounderline abstract_t">Vasa-Nicotera M, Sinning JM, Chin D, et al. Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012; 5:858.</a></li><li><a class="nounderline abstract_t">Padang R, Ali M, Greason KL, et al. Comparative survival and role of STS score in aortic paravalvular leak after SAVR or TAVR: a retrospective study from the USA. BMJ Open 2018; 8:e022437.</a></li><li><a class="nounderline abstract_t">Aronow WS, Kronzon I. Correlation of prevalence and severity of mitral regurgitation and mitral stenosis determined by Doppler echocardiography with physical signs of mitral regurgitation and mitral stenosis in 100 patients aged 62 to 100 years with mitral anular calcium. Am J Cardiol 1987; 60:1189.</a></li><li><a class="nounderline abstract_t">Labovitz AJ, Nelson JG, Windhorst DM, et al. Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography. Am J Cardiol 1985; 55:133.</a></li><li><a class="nounderline abstract_t">Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 1987; 62:22.</a></li><li><a class="nounderline abstract_t">Jebara VA, Dervanian P, Acar C, et al. Mitral valve repair using Carpentier techniques in patients more than 70 years old. Early and late results. Circulation 1992; 86:II53.</a></li><li><a class="nounderline abstract_t">Hendren WG, Nemec JJ, Lytle BW, et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg 1991; 52:1246.</a></li><li><a class="nounderline abstract_t">Lee EM, Porter JN, Shapiro LM, Wells FC. Mitral valve surgery in the elderly. J Heart Valve Dis 1997; 6:22.</a></li><li><a class="nounderline abstract_t">Grossi E. Mitral valve repair in the elderly. Cardiol Elderly 1995; 3:269.</a></li><li><a class="nounderline abstract_t">Goldsmith I, Lip GY, Kaukuntla H, Patel RL. Hospital morbidity and mortality and changes in quality of life following mitral valve surgery in the elderly. J Heart Valve Dis 1999; 8:702.</a></li><li><a class="nounderline abstract_t">Asimakopoulos G, Edwards MB, Brannan J, Taylor KM. Survival and cause of death after mitral valve replacement in patients aged 80 years and over: collective results from the UK heart valve registry. Eur J Cardiothorac Surg 1997; 11:922.</a></li><li><a class="nounderline abstract_t">Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients &gt; or = 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000; 35:731.</a></li><li><a class="nounderline abstract_t">Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004; 110:356.</a></li><li><a class="nounderline abstract_t">Enriquez-Sarano M, Schaff HV, Frye RL. Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation 2003; 108:253.</a></li><li><a class="nounderline abstract_t">Thourani VH, Weintraub WS, Guyton RA, et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation 2003; 108:298.</a></li><li><a class="nounderline abstract_t">Grossi EA, Zakow PK, Sussman M, et al. Late results of mitral valve reconstruction in the elderly. Ann Thorac Surg 2000; 70:1224.</a></li><li><a class="nounderline abstract_t">Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 2006; 114:265.</a></li><li><a class="nounderline abstract_t">Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364:1395.</a></li><li><a class="nounderline abstract_t">Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med 2018; 379:2297.</a></li><li><a class="nounderline abstract_t">Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018; 379:2307.</a></li><li><a class="nounderline abstract_t">Iung B, Cormier B, Farah B, et al. Percutaneous mitral commissurotomy in the elderly. Eur Heart J 1995; 16:1092.</a></li><li><a class="nounderline abstract_t">Sutaria N, Elder AT, Shaw TR. Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over. Heart 2000; 83:433.</a></li><li><a class="nounderline abstract_t">Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43:405.</a></li><li><a class="nounderline abstract_t">Lee JW, Song JM, Park JP, et al. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 2010; 74:375.</a></li><li><a class="nounderline abstract_t">Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 2012; 5:314.</a></li><li><a class="nounderline abstract_t">Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Excess mortality due to coronary artery disease after valve surgery. Secular trends in valvular regurgitation and effect of internal mammary artery bypass. Circulation 1998; 98:II108.</a></li><li><a class="nounderline abstract_t">Davis EA, Gardner TJ, Gillinov AM, et al. Valvular disease in the elderly: influence on surgical results. Ann Thorac Surg 1993; 55:333.</a></li></ol></div><div id="topicVersionRevision">Topic 8147 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Spencer, G. US bureau of the census: Projections of the population of the united states, by age, sex and race: 1988 to 2080. Current Population 1989. p.1018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16980116" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Burden of valvular heart diseases: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1452924" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Aortic valve replacement in octogenarians with aortic stenosis: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8733092" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9377949" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prognosis and quality of life after valve surgery in patients older than 75 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21639811" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Transcatheter versus surgical aortic-valve replacement in high-risk patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20961243" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12831818" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8712130" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Natural history of aortic valve stenosis of varying severity in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8459080" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1826070" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2148732" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Cardiac findings in the very elderly: analysis of echocardiography in fifty-eight nonagenarians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3807436" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15710758" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16864725" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9060903" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10403851" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33332150" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34453165" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : 2021 ESC/EACTS Guidelines for the management of valvular heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29566814" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Reduced Left Ventricular Ejection Fraction in Patients With Aortic Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8222145" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Aortic valve replacement in patients 80 years and older. Operative risks and long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10386757" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Aortic valvular replacement in octogenarians. Short-term and mid-term results in 140 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10409525" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Surgery for aortic stenosis in severely symptomatic patients older than 80 years: experience in a single UK centre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1904893" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9396434" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9307446" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Cardiac operations in patients 80 years old and older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10716479" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Observed and relative survival after aortic valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10843828" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26610876" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26436963" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7646163" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11028464" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12651032" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Choice of prosthetic heart valve for adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15867191" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Use of heart valves in older patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25791947" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8000588" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Long-term clinical outcome with small size Standard St Jude Medical valves implanted in the aortic position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9587864" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Impact of prosthesis-patient mismatch on hemodynamic and symptomatic status, morbidity and mortality after aortic valve replacement with a bioprosthetic heart valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8953455" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Aortic valve replacement for aortic stenosis in patients with small aortic root.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8179372" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The risk of small St. Jude aortic valve prostheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10534686" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Impact of small prosthetic valve size on operative mortality in elderly patients after aortic valve replacement for aortic stenosis: does gender matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9124972" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Nineteen-millimeter aortic St. Jude Medical heart valve prosthesis: up to sixteen years' follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9768918" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Aortic valve replacement for octogenarians: are small valves bad?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8186557" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Prosthetic valves for the small aortic root.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19118723" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9205157" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Aortic valve replacement with patch enlargement of the aortic annulus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9699575" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Aortic valve replacement with stentless and stented porcine valves: a case-match study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10440649" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Aortic valve replacement with stentless porcine bioprostheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25257633" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26614412" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1527289" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8971510" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Aortic valve replacement after aortic valvuloplasty for calcified aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17389271" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8665969" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7955254" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Aortic valve replacement in adults after balloon aortic valvuloplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23680956" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18820172" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10190406" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22443479" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Two-year outcomes after transcatheter or surgical aortic-valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22917458" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30530577" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Comparative survival and role of STS score in aortic paravalvular leak after SAVR or TAVR: a retrospective study from the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3687754" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Correlation of prevalence and severity of mitral regurgitation and mitral stenosis determined by Doppler echocardiography with physical signs of mitral regurgitation and mitral stenosis in 100 patients aged 62 to 100 years with mitral anular calcium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3966372" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3796056" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1424034" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Mitral valve repair using Carpentier techniques in patients more than 70 years old. Early and late results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1755677" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Mitral valve repair for ischemic mitral insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9044072" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Mitral valve surgery in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Mitral valve repair in the elderly</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10616251" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Hospital morbidity and mortality and changes in quality of life following mitral valve surgery in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9196310" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Survival and cause of death after mitral valve replacement in patients aged 80 years and over: collective results from the UK heart valve registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10716477" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Outcomes of cardiac surgery in patients&gt;or = 80 years: results from the National Cardiovascular Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15249504" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12876134" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12835220" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11081875" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Late results of mitral valve reconstruction in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16847151" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21463154" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Percutaneous repair or surgery for mitral regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30145927" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30280640" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Transcatheter Mitral-Valve Repair in Patients with Heart Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8665971" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Percutaneous mitral commissurotomy in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10722546" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15013122" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Impact of tricuspid regurgitation on long-term survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20009355" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Long-term prognosis of isolated significant tricuspid regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22447806" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9852890" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Excess mortality due to coronary artery disease after valve surgery. Secular trends in valvular regurgitation and effect of internal mammary artery bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8431037" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Valvular disease in the elderly: influence on surgical results.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
